Aspirin might have antioxidant properties and plays an important role in inflammation. Promising evidence from the in vitro fertilization (IVF) literature suggests that low-dose aspirin may improve fecundity, possibly due to improved perfusion early in pregnancy. We conducted a meta-analysis of randomized IVF clinical trials that suggested that aspirin during early gestation may reduce the risk of preterm birth and small-for-gestational-age babies. The EAGeR study will be a multi-site, double-blinded randomized trial designed to assess the effects of low-dose aspirin on implantation and pregnancy outcome. It will be the largest such study to-date, enrolling 1,600 women experiencing a recent pregnancy loss who are planning subsequent pregnancies. Each woman will be randomly assigned to the treatment group with 81 mg aspirin plus 0.4 mg folic acid daily or the placebo group with 0.4 mg folic acid only. Treatment/placebo administration will start prior to conception and continue during pregnancy. Fertility monitors will be used to assist with timing of intercourse, home digital pregnancy testing kits will be used to determine pregnancy, and daily urine samples will be collected to monitor very early pregnancy and pregnancy loss. Pregnancy loss, pregnancy complications and perinatal outcomes will be monitored throughout pregnancy. We hypothesize that low-dose aspirin may reduce oxidative stress and inflammation and, therefore, reduce vascular resistance and improve blood flow and placental perfusion. An increased supply of oxygen and nutrients should promote placental and fetal growth, enhance conception rates, reduce pregnancy loss and pregnancy complications and, thereby, improve perinatal outcomes. Findings from this trial will have important implications not only for women trying to conceive but also for women who want to maintain a healthy pregnancy and achieve optimal perinatal outcomes. We will utilize the methods we have developed related to pooling in certain sub-studies, such as the study of compliance with assigned treatment.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2011
Total Cost
$325,000
Indirect Cost
City
State
Country
Zip Code
Radin, Rose G; Sjaarda, Lindsey A; Perkins, Neil J et al. (2017) Low-Dose Aspirin and Sporadic Anovulation in the EAGeR Randomized Trial. J Clin Endocrinol Metab 102:86-92
Pugh, Sarah J; Schisterman, Enrique F; Browne, Richard W et al. (2017) Preconception maternal lipoprotein levels in relation to fecundability. Hum Reprod 32:1055-1063
Sjaarda, Lindsey A; Radin, Rose G; Silver, Robert M et al. (2017) Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. J Clin Endocrinol Metab 102:1495-1504
Schliep, Karen C; Mitchell, Emily M; Mumford, Sunni L et al. (2016) Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait. Obstet Gynecol 127:204-12
Schliep, Karen C; Mumford, Sunni L; Sjaarda, Lindsey A et al. (2016) In Reply. Obstet Gynecol 127:1171
Plowden, Torie C; Schisterman, Enrique F; Sjaarda, Lindsey A et al. (2016) Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth. J Clin Endocrinol Metab 101:2358-65
Plowden, Torie C; Schisterman, Enrique F; Sjaarda, Lindsey A et al. (2016) Response to Letter: Are We Really Sure that Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth? J Clin Endocrinol Metab 101:L87-8
Zarek, Shvetha M; Mitchell, Emily M; Sjaarda, Lindsey A et al. (2016) Antim├╝llerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial. Fertil Steril 105:946-952.e2
Ahrens, Katherine A; Silver, Robert M; Mumford, Sunni L et al. (2016) Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses. Obstet Gynecol 127:689-98
Hinkle, Stefanie N; Mumford, Sunni L; Grantz, Katherine L et al. (2016) Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med 176:1621-1627

Showing the most recent 10 out of 35 publications